Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)
Hong Kong · Delayed Price · Currency is HKD 90.00
+0.35 (0.39%)
At close: Apr 20, 2026
HKG:2659 Market Cap
HKG:2659 has a market cap or net worth of 29.22 billion as of April 20, 2026.
Market Cap
29.22B
Enterprise Value
28.19B
Revenue
54.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
90.00
Market Cap Chart
Since December 10, 2025, HKG:2659's market cap has increased from 20.54B to 29.22B, an increase of 42.30%. That is a compound annual growth rate of 173.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 29.22B | 15.60% |
| Dec 31, 2025 | 25.28B | 23.10% |
| Dec 10, 2025 | 20.54B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shanghai Junshi Biosciences | 47.19B |
| Shanghai Henlius Biotech | 45.90B |
| Biocytogen Pharmaceuticals (Beijing) | 44.57B |
| InnoCare Pharma | 31.93B |
| Genscript Biotech | 30.11B |
| Duality Biotherapeutics | 28.05B |
| TransThera Sciences (Nanjing) | 27.61B |
| Keymed Biosciences | 23.35B |